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Objective: Tissue inhibitor of metalloproteinase 3 (TIMP3) is an extracellular matrix (ECM) bound protein, which has been shown to be
downregulated in human subjects and experimental models with cardiometabolic disorders, including type 2 diabetes mellitus, hypertension and
atherosclerosis. The aim of this study was to investigate the effects of TIMP3 on cardiac energy homeostasis during increased metabolic stress
conditions.
Methods: ApoE/TIMP3/ and ApoE/ mice on a C57BL/6 background were subjected to telemetric ECG analysis and experimental
myocardial infarction as models of cardiac stress induction. We used Western blot, qRT-PCR, histology, metabolomics, RNA-sequencing and
in vivo phenotypical analysis to investigate the molecular mechanisms of altered cardiac energy metabolism.
Results: ApoE/TIMP3/ revealed decreased lifespan. Telemetric ECG analysis showed increased arrhythmic episodes, and experimental
myocardial infarction by left anterior descending artery (LAD) ligation resulted in increased peri-operative mortality together with increased scar
formation, ventricular dilatation and a reduction of cardiac function after 4 weeks in the few survivors. Hearts of ApoE/TIMP3/ exhibited
accumulation of neutral lipids when fed a chow diet, which was exacerbated by a high fat, high cholesterol diet. Metabolomics analysis revealed
an increase in circulating markers of oxidative stress with a reduction in long chain fatty acids. Using whole heart mRNA sequencing, we identified
apelin as a putative modulator of these metabolic defects. Apelin is a regulator of fatty acid oxidation, and we found a reduction in the levels of
enzymes involved in fatty acid oxidation in the left ventricle of ApoE/TIMP3/ mice. Injection of apelin restored the hitherto identified
metabolic defects of lipid oxidation.
Conclusion: TIMP3 regulates lipid metabolism as well as oxidative stress response via apelin. These findings therefore suggest that TIMP3
maintains metabolic flexibility in the heart, particularly during episodes of increased cardiac stress.
 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Chronic heart diseases lead to cardiac remodeling, a phenomenon
that, besides structural changes, results in an impaired ability of
cardiac myocytes to shift between nutrient substrate usage in order to
adapt to energetic needs [1]. Several cellular fuel gauges such as
AMPK have been found to contribute to the regulation of synchronicity
between tissue function and metabolic fluxes in the heart [1]. However,
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The ECM may be relevant in different chronic heart diseases [3], but
how its components interact with intracellular signaling pathways to
facilitate dynamic changes in heart metabolism is unknown.
We have recently focused on Tissue inhibitor of Metalloproteinase 3
(TIMP3), an ECM-bound protein, modulating metalloprotease and
angiogenic receptors that is downregulated in human subjects and
experimental models with metabolic and inflammatory disorders such
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Original articleTIMP3 blocks the release of TNF-alpha and EGFR ligands (including
TGF-alpha, amphiregulin) mediated by ADAM17. TIMP3 also blocks the
activity of metalloproteases such as MMP9 and MMP14, which play a
role in progression of heart disease. Finally, TIMP3 blocks the acti-
vation of VEGRF2 with a final effect to stabilize the angiogenic process
to obtain a mature tube stabilization [13e16].
Previous work showed that loss of TIMP3 accelerates cardiovascular
disorders including dilated and hypertrophic cardiomyopathies,
abdominal aortic aneurysm and hypertension related vessel remodeling
[17,18] mediated by TNF-alpha, Angiotensin II and metalloproteases.
Functional re-expression of TIMP3 via cell-based, vector delivery, or
intravenous administration proved a protective role for TIMP3 against
complications of myocardial infarction such as cardiac rupture,
ischemic related cardiomyopathy and heart fibrosis and pressure
overload, suggesting a putative therapeutic role for this protein to
preserve tissue integrity, in part via its ability to maintain vasculature
structure and mesenchymal stem cell functions [19e21].
The role of TIMP3 in the context of cardiovascular remodeling is
relatively unexplored when considering classical risk factors such as
hypercholesterolemia, diabetes and hypertension. We have observed
that increased levels of TIMP3 released from inflammatory cells
partially protect from atherosclerosis progression in a combined ge-
netic and dietetic model, the low density lipoprotein receptor knockout
(LDLR/) mice fed a western diet [10]. Observational studies in
subjects with congestive heart failure suggested that TIMP3 might be
deficient in the myocardial tissues [22]. We recently described
increased atherosclerosis at the aortic level in the ApoE/TIMP3/
mouse model. Here, we demonstrate that ApoE/TIMP3/ mice
show decreased lifespan at the baseline and a reduced resistance to
cardiac stress. To investigate this phenotype in more depth, we
combined genetics, metabolomics and in vivo phenotypical analysis.
Collectively, metabolite profiling and gene and protein expression
consistently suggested that the loss of TIMP3 leads to a perturbation of
metabolic flexibility in the heart and arrhythmias, phenomena that may
underlie the increased rates of cardiovascular death in this model
independently from its atherosclerotic background.
2. MATERIALS AND METHODS
2.1. Experimental animal procedures and metabolic tests
All animal procedures were performed in accordance to the Guide for
the Care and Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85e23, revised 1996),
approved by the University Hospital of Tor Vergata Animal Care Facility
and previously described [23]. ApoE/ TIMP3/ mice have previ-
ously been described [24]. The genotype was confirmed also assaying
TIMP3 protein levels and activity of its substrate Matrix Metal-
loproteinase 9 (Supplementary Figure S1A-B).
Animals were housed in shoebox-sized cages with free access to
water and food on a 12 h dayenight cycle. Where specified, animals
were fed a Western diet (0.5% cholesterol, 45% calories from fat;
Research Diets, New Brunswick, NJ) while all other animals received
normal chow food (10% calories from fat; GLP Mucedola Srl, Settimo
Milanese, Italy).
Glucose levels were measured in the fasting or fed state as indicated
with an OneTouch Lifescan Glucometer. Plasma apelin was measured
by ELISA (USCN Lifescience) after overnight fast. All tissues were
collected in the fasting or the fed state as indicated and stored at80.
For fasting experiments, animals were fasted for 16 h.
Intraperitoneal glucose tolerance test (IPGTT) was performed after
overnight fast. In brief, after a 16 h fast, animals were challenged with742 MOLECULAR METABOLISM 4 (2015) 741e752  2015 The Authors. Published by Elsevier Gmbglucose (2 g/kg) injected intraperitoneally and blood was collected after
30, 60, 90 and 120 min and analyzed with a glucometer. Intraperi-
toneal insulin tolerance test (ITT) was performed after a 4 h fast. In
brief, animals were challenged with insulin (0.75 U/kg) and blood was
collected after 10, 30, 60 and 90 min and analyzed with a glucometer.
2.2. ECG telemetry
ECG recordings were taken in freely moving mice, monitored with a
signal transmitter receiver connected to a data acquisition system
(Data Sciences International, St Paul, USA.). Data were collected at
1,000 Hz and analyzed with ECG auto software Dataquest Ponemah
4.9 system (Data Sciences International). ECG was continuously
recorded for 48 h per mice.
2.3. Acute myocardial infarction model
Ligation of the left anterior descending artery (LAD) was performed as
a model of myocardial infarction as previously described [25] and is
explained in more detail in the supplementary data.
2.4. Indirect calorimetry
Indirect calorimetry was conducted in ApoE/TIMP3/ mice (n ¼ 4)
and ApoE/mice (n ¼ 4) as well as in a second experiment after
intraperitoneal apelin injections in ApoE/TIMP3/ and ApoE/
mice (n ¼ 5e6 per group). All mice were acclimatized for 24 h to the
metabolic cages. O2 consumption (VO2) and CO2 production (VCO2)
weremeasured (TSE Systems, Germany) [26] inmice at 15min intervals
during a 24 h period in the fed state as well as during a 12 h period in the
fasting state. Respiratory exchange ratio (RER) (¼ VCO2/VO2) and lipid
oxidation rates {¼ [1.672  (VO2  VCO2)]} were calculated.
2.5. Apelin supplementation
For apelin supplementation studies, Pyr-13 apelin was purchased from
DBA Italia and resuspended in PBS. For intraperitoneal injections, a
concentration of 0.1 mmol/kg was used as previously described [27].
Control animals received matched volumes of PBS alone.
2.6. Gene expression analysis by qRT-PCR
Total RNA was isolated from liver, heart and muscle using Trizol re-
agent (Invitrogen Corp, Carlsbad, CA). Two micrograms of total RNA
were reverse-transcribed into complementary DNA (cDNA) using the
High Capacity cDNA Archive kit (Applied Biosystems, Foster City, CA).
Quantitative real-time polymerase chain reaction was performed using
an ABI PRISM 7700 System and TaqMan reagents (Applied Bio-
systems). Each reaction was performed in triplicate using standard
reaction conditions and results were normalized by b-actin. Data were
submitted to Gene Expression Omnibus (GEO) (GSE53548) [NCBI
tracking system #16936641].
2.7. Metabolomics
For Metabolomics analysis, the serum of 6 male ApoE/ and 6 male
ApoE/TIMP3/ was collected in the fasted state. Metabolomics
assays were performed in service at Metabolon Laboratory and are
described in detail in the supplementary data.
2.8. mRNA profiling and analysis
Total RNA was isolated from hearts of ApoE/ and ApoE/TIMP3/
mice using Trizol reagent (Invitrogen Corp, Carlsbad, CA). mRNA
sequencingwas commercially performed at DNAVISION facility (Charleroi,
Belgium). RNA libraries were prepared for sequencing using standard
Illumina protocols. RNA-Sequencing profiling was performed by the
Illumina HiSeq2000 platform. FastQC tool was used for the quality checkH. This is an open accessarticle under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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of sequenced samples. For data analysis, a pipeline combining TopHat
(http://tophat.cbcb.umd.edu) and Cufflinks (http://cuffinks.cbcb.umd.
edu) was used to identify transcripts in each sample. TopHat uses the
Bowtie aligner to produce alignment and to discover splice junctions.
Cufflinks assembles transcripts, estimates their abundances, and tests
for differential expression and regulation. Reads were aligned against the
mouse reference genome (NCBIM37.60) and the identified transcripts
were compared to those annotated in the reference genome. The metric
used by Cufflinks to estimate the abundance of transcripts is the FPKM:
Fragments Per Kilobase of exon per Million fragments mapped. For heat
maps and hierarchical clustering MultiExperiment Viewer was used [28].
Differential exons were computed by EdgeR package in Bioconductor.
Data were submitted to GEO (GSE53548) [NCBI tracking system
#16936641].
2.9. Statistical analysis
Results of the experimental studies are mean  SEM. Statistical an-
alyses were performed using the unpaired Student’s t test and one-
way-ANOVA with GraphPAD Prism 6.0 if not otherwise specified.A
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Cox Test). B) Telemetry 24 h ECG in 32-weeks-old ApoE/TIMP3/ and ApoE/ mice.
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and compared by using the Log-Rank test. Values of p < 0.05 were
considered statistically significant.
3. RESULTS
3.1. ApoE/TIMP3/ mice have increased cardiac mortality
A combined retro- and prospective 52 weeks analysis of ApoE/
TIMP3/ (n ¼ 32) mice revealed a decreased survival rate when
compared to ApoE/ (n ¼ 32) littermates (p ¼ 0.0002, Cox Test;
Figure 1A), with the first episodes of death observed at week 28 in the
ApoE/TIMP3/ group. The higher mortality rate in the ApoE/
TIMP3/ group was independent from gender and no differences be-
tween genotypes for specific macroscopic signs of infections including
dermatitis or sudden loss of body weight were observed. Since necro-
scopy of ApoE/TIMP3/mice did not reveal any obvious sign such as
bleeding, malignancy or macroscopically visible organ pathology
responsible for decreased lifespan, we speculated that mice might suffer
from sudden cardiac death.RRHYTHMIA (TA): 
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We observed a higher amount of arrhythmic episodes in ApoE/TIMP3/ as well as
act test). C) Increased peri-operative mortality during experimental myocardial infarction
by Chi-square test). D) Representative photomicrographs of Masson-Trichrome stained
orphometric quantification of percent total LV circumference. Data are mean  SEM
tolic (dp/dtmin) heart function in ApoE/TIMP3/ mice 4 weeks after LAD ligation as
4e5 per group).
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Original articleTo test this hypothesis of increased cardiac mortality, we subjected
ApoE/TIMP3/ mice and ApoE/ littermates to two different
models of cardiac stress: invasive telemetry 24 h ECG and LAD ligation.
We first performed invasive 24 h ECG recordings to investigate the
presence of anomalous electrical activity in 32-weeks-old ApoE/
TIMP3/ and ApoE/ mice. We observed a higher amount of
arrhythmic episodes in ApoE/TIMP3/ mice (Figure 1B) as well as
sudden deaths in 4 out of 6 ApoE/TIMP3/ male mice during the
7-day registration period (p ¼ 0.06, Fisher Exact test).
In the second model of cardiac stress induction, ApoE/TIMP3/
and ApoE/ mice were subjected to LAD ligation as previously
described. In the ApoE/TIMP3/ cohort, we observed signifi-
cantly increased peri-operative mortality compared with ApoE/
mice with 13/19 mice dying within 24 h of the intervention compared
to 2/13 deaths in the ApoE/ group (p < 0.0001, Chi-square test,
Figure 1C). Although we cannot measure the occurrence of ar-
rhythmias in this experiment, we did not observe bleeding or other
operative complications between the 2 groups. In the few survivors,
histological analysis of the ventricle showed extension of the
infarction area (p < 0.05, Student’s t-test, n ¼ 3e4 per group,
Figure 1D) as well as increased ventricular remodeling and dilatationA
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Figure 2: ApoEL/LTIMP3L/L animals show increased deposition of neutral lipid
myocardium of 6e8 month old ApoE/TIMP3/ and ApoE/ mice on normal chow diet
to 8 month old mice fed a Western diet for 8 weeks stained with ORO showing increased li
Student t-test, n ¼ 4 per group). Magnification further displays globular intracellular lipid ac
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744 MOLECULAR METABOLISM 4 (2015) 741e752  2015 The Authors. Published by Elsevier Gmbin the ApoE/TIMP3/ mice (Figure 1D). Invasive cardiac function
4 weeks post LAD ligation revealed reduced systolic and diastolic
function in ApoE/TIMP3/ mice (p < 0.05 for both, Student’s t-
test, Figure 1E).
3.2. ApoE/TIMP3/ mice show lipid accumulation in heart
To gain further insight into structural changes within the heart of
ApoE/TIMP3/ mice leading to arrhythmias and sudden cardiac
death, we performed echocardiographic and histological analyses.
As expected ApoE/TIMP3/ mice revealed signs of mild athero-
sclerosis in both coronary and carotid arteries but no signs of athe-
rothrombosis (Supplementary Figure S2AeB). Left ventricular function
as measured with echocardiography did not differ between the groups
(Supplementary Figure S2C).
However, staining of heart sections with Oil Red O revealed focal
intracellular accumulation of lipid droplets in the hearts of the ApoE/
TIMP3/ mice, a phenomenon absent in ApoE/ mice fed a normal
diet at 24 weeks of age (Figure 2A). When both mouse strains were fed
a Western diet for 8 weeks we observed intense and significant higher
lipid accumulation in the ApoE/TIMP3/ group compared with
ApoE/ mice (p < 0.05, Student’s t-test, Figure 2B).imp3-/-
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3.3. Metabolic characterization of ApoE/TIMP3/ mice reveals
impaired lipid oxidation
ApoE/TIMP3/ mice further showed a complex metabolic
phenotype characterized by a trend to lower fasting glucose, a normal
Glucose Tolerance Test (GTT) coupled to mild insulin resistance during
the Insulin Tolerance Test (*p < 0.05, ***p < 0.001, Student’s t test,
Figure 3AeC).
Whole-body indirect calorimetry of ApoE/TIMP3/ compared to
ApoE/ mice revealed no difference in the fed state (data not shown).
However, because the observed differences in the fasting glucose, we
repeated the whole-body indirect calorimetry during 12 consecutive
hours of fasting conditions. While no differences were observed in the
0e8 h interval (data not shown), we observed that in the interval from
8 to 12 h of fasting the RER was significantly increased due to
significantly reduced lipid oxidation (both p < 0.05, Student’s t test,
Figure 3D).
3.4. Metabolomics analysis revealed changes in biomarkers of
antioxidant defense, lipid metabolism and sphingolipid pathway
To unveil biomarkers associated to the reduced lifespan and impaired
lipid oxidation, we performed metabolomics analysis in ApoE/ and
ApoE/TIMP3/. Random Forest analysis of the analyzed bio-
chemicals resulted in a predictive accuracy of 83% in classifying be-
tween ApoE/ and ApoE/TIMP3/ mice (Supplementary
Figure S3). Several metabolites were differently regulated in the
ApoE/TIMP3/ compared with ApoE/ littermates (SupplementaryA B
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www.molecularmetabolism.comTables S1 and S2). In the serum of ApoE/TIMP3/ mice, we
observed complex modulation of pathways linked to oxidative stress as
demonstrated by the depletion of ergothioneine, equol sulfate, cysteine-
glutathione disulfide and oxidized glutathione while 2-hydroxybutyrate
and 2-aminobutyrate were increased (Figure 4A,B). ApoE/TIMP3/
mice also showed reductions in long-chain monounsaturated FFAs such
as 10-nonadecenoate and 10-heptadecenoate, medium-chain acyl-
carnitines such as hexanoylcarnitine, medium-chain acyl-glycine (i.e.,
valerylglycine) and the medium-chain fatty acid marker of beta-
oxidation, 3-hydroxydecanoate (Figure 5A,B). On the other hand, the
long-chain acyl-carnitine stearoylcarnitine was significantly elevated in
ApoE/TIMP3/ mice (Figure 5A,B). ApoE/TIMP3/ mice also
showed altered sphingolipid metabolism with increased levels of pal-
mitoyl sphingomyelin, stearoyl sphingomyelin, 1-stearoylglycerol and
sphingosin that can be in part connected to increased stearoylcarnitine
and its derivatives (Figure 6A,B).
3.5. Reduced expression of enzymes involved in fatty acid
oxidation in ApoE/TIMP3/ mice
The relative deficiency of long-chain fatty acids along with the
concomitant build-up of stearoylcarnitine could reflect a deficiency in
stearoyl-CoA desaturase 1 (SCD1) within different tissues. We therefore
screened the expression of genes related to the regulation of glucose
and lipid metabolism in ApoE/TIMP3/ compared with ApoE/
mice in the liver, skeletal muscle and heart. In the liver, we found
reduced mRNA expression for PPARa, SCD1, ACADM, ACADL, ACADVL150
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Original articleand FoxO1 (Supplementary Table S3). In skeletal muscle, no important
differences were found (Supplementary Table S3). In the hearts of
ApoE/TIMP3/ mice, we found significantly decreased expression
of PPARa and its targets SCD1, ACADM and a trend for decreased
expression of other enzymes involved in fatty acid oxidation such as
ACADL and ACADVL (Table 1). Interestingly, we also found decreased
expression of FoxO1, a regulator of oxidative stress and autophagy, and
its targets PDK4, ATG5, ATG8, BECN1, LC3, ULK1 (Table 1).
3.6. Whole heart mRNA sequencing revealed reduced apelin in
ApoE/TIMP3/ mice
To gain insight into the regulation of glucose and lipid metabolism of the
heart by TIMP3 we performed mRNA transcriptomic analysis by Next
Generation Sequencing (Illumina) of the heart in ApoE/TIMP3/ and
ApoE/ littermates. We identified several significantly upregulated and
downregulated transcripts from ApoE/TIMP3/ compared with
ApoE/ littermates (Supplementary Figure S4A and Supplementary
Table S4). Among the downregulated transcripts, confirmed after
qPCR, we found apelin (Supplementary Figure S4A,B), which we
confirmed to be significantly reduced in heart tissue but not in the
epididymal White Adipose Tissue (eWAT), muscle and liver from ApoE/746 MOLECULAR METABOLISM 4 (2015) 741e752  2015 The Authors. Published by Elsevier GmbTIMP3/ mice by quantitative PCR (*p < 0.05, Student’s t test,
Figure 7A). Apelin blood levels measured by ELISA were shown to be
significantly lower in the ApoE/TIMP3/ compared with ApoE/
littermates (*p < 0.05, Student’s t test, Figure 7B).
3.7. Apelin injection rescues metabolic phenotype in
ApoE/TIMP3/ mice
Finally, we reasoned that injecting apelin in vivo could lead to
improvement of metabolic defects observed in ApoE/TIMP3/
mice. Indirect calorimetry was performed in fasted ApoE/TIMP3/
mice and ApoE/ littermates after a single intraperitoneal apelin in-
jection; control animals received a matched volume of PBS (per group
n¼ 5e6; values reported in the bar graph were obtained in the interval
of prolonged fasting (8e12 h interval)). Apelin injection significantly
reduced RER in ApoE/TIMP3/ mice (****p < 0.001, one-way
ANOVA, Figure 7C) to an extent comparable to PBS-injected ApoE/
littermates. RER: 0.80 0.02 (ApoE/ PBS) vs. 0.79 0.02 (ApoE/
TIMP3/ apelin), not significant, Figure 7C). Consequently, apelin
increased lipid oxidation in ApoE/TIMP3/ mice and in ApoE/
mice, although to a lesser extent (****p < 0.001, one-way ANOVA,
Figure 7C).H. This is an open accessarticle under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The phenotype of the ApoE/TIMP3/mice revealed new, unpredicted
findings linking TIMP3 to metabolic flexibility in the heart. Although,
compared to control ApoE/ littermates, the ApoE/TIMP3/ mice
showed mild increased atherosclerotic plaques and fatty streaks at the
aortic roots and the peripheral aorta, the differences were less consistent
in the coronary and carotid arteries. It is possible, therefore, that the
causes of sudden death are not linked to plaque instability and a possible
metabolic origin of the phenotype cannot be excluded. Previous work on
the combined ApoE and high-density lipoprotein receptor SR-BI (SR-BI)
double knockout revealed early lethality due to increased coronary
atherosclerosis combinedwith lipid accumulation in the left ventricle [29].
The ApoE/TIMP3/ mice showed similar globular intracellular lipid
accumulation, and when shifted to Western diet, a punctate pattern
reminiscent of extracellular lipid deposition [29].
However, differently from the ApoE/SR-BI/ model, the ApoE/
TIMP3/ mice revealed increased lethality at an older age or when
subjected to stress conditions like telemetry or experimental
myocardial infarction, suggesting that the effect may be partially age-
and environment dependent, as already observed with TIMP3 in other
cardiovascular models [15,16].
Metabolomics data allows for a hypothesis that explains the increased
susceptibility of ApoE/TIMP3/ mice to cardiovascular diseases.MOLECULAR METABOLISM 4 (2015) 741e752  2015The Authors. Published by Elsevier GmbH. This is an open
www.molecularmetabolism.comFirst, ApoE/TIMP3/ mice have defective control of oxidative
stress. In particular, they show a state of depletion of dietary antiox-
idants such as ergothioneine and equol sulfate [30, 31] coupled to the
decrease of some indicators of oxidation such as cysteine-glutathione
disulfide and oxidized glutathione. Similarly, we found increased
concentrations of 2-hydroxybutyrate and 2-aminobutyrate, both being
derived from the common precursor alpha-ketobutyrate, the levels of
which increase when demand for glutathione is high. Since it has been
reported that ischemia induces glutathione depletion via osmotic stress
[32], it is intriguing to hypothesize that TIMP3 deficiency in the heart
mimics the effect of modified lipoproteins and oxysterols to provoke an
ischemia-like metabolic alterations at the myocardial level although we
cannot exclude the involvement of other tissues [33,34].
Secondly, analysis of sphingolipid metabolism displayed deep per-
turbations in ApoE/TIMP3/ mice. Glutathione depletion has been
shown to regulate sphingomyelin metabolism [35], and the loss of an
oxidative stress response might be responsible for those alterations. In
patients with transient ischemia, and thus increased cardiac stress,
increased levels of sphingosine have been found [36]. Further, alter-
ations of sphingolipid metabolism have been reported in rats subjected
to LAD ligation [37] and in models of ischemia/reperfusion injury
[38,39].
Although, we could not identify ceramide itself in the metabolomics
analysis, it is a crucial intermediate of sphingolipid metabolismaccessarticle under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 747
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Original article(Figure 6B) and has been associated with the dysfunction of the human
ether-a-go-go related gene (HERG) Kþ channel, which, again, is
associated with prolongation of the QT interval and arrhythmias [40].
Therefore, perturbations in sphingolipid metabolism might contribute
in increased arrhythmias in the ApoE/TIMP3/ mice.
Thirdly, the circulating metabolite profiles suggest that in the face of
mild insulin resistance, the loss of TIMP3 in the hypercholesterolemic
background is characterized by a block of fatty acid oxidation at
the stearoyl-CoA level. This may prompt increased rates of
glucose oxidation to support energetic demands. Mice with
stearoyl-CoA desaturase 1 deficiency reveal a similar phenotype to
ApoE/TIMP3/ mice, with increased myocardial glucose utilization
and impaired fatty acid oxidation [41]. The limited gene expression
screening that we performed in the liver and the muscle confirmed that
in this specific context the defective fatty acid oxidation is more
prevalent at the cardiovascular level. Therefore, in a TIMP3 deficient
state it appears that the heart may be less efficient at compensating for
energetic demands during acute stress.
Adult cardiomyocytes produce most energy via fatty acid oxidation
(FAO) but retain capacity to readily switch to glucose or other substrate748 MOLECULAR METABOLISM 4 (2015) 741e752  2015 The Authors. Published by Elsevier Gmbutilization when fatty acid is not available or FAO is compromised [1].
Indeed, when subjecting the myocardium to acute oxidative stress and
energy depletion in the model of myocardial infarction, there is an
increased mortality, which could be explained by an inability to utilize
all metabolic pathways available to produce energy. One may postulate
that the lower fasting glucose observed in the ApoE/TIMP3/ mice
results from a switch to glucose oxidation that impairs a further in-
crease energy production thus ultimately leading to cell death. The
reduction PPARa and some of its target genes involved in fatty acid
oxidation (such as Hadha Hadhb ACADS ACADM ACADVL) might in part
explain the phenotype of the ApoE/TIMP3/ mice. In fact,
myocardial lipid accumulation and hypoglycemia also characterize the
adult mice lacking PPARa [42]. Similarly to the ApoE/TIMP3/,
deletion of PPARa results in decreased expression of fatty acid b-
oxidation genes accompanied by a decrease in fatty acid b-
oxidation and a parallel increase in glucose oxidation [42e46]. The
ApoE/TIMP3/model may also recall the phenotype characterizing
a model of cardiovascular insulin resistance, the Cardiac Insulin Re-
ceptor Knockout (CIRKO) mice, in which PPARa and several FAO genes
are repressed [47]. Further, we observed a downregulation ofH. This is an open accessarticle under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
www.molecularmetabolism.com
Table 1 e Loss of TIMP3 leads to altered expression of genes involved in fatty acid metabolism in heart.
Heart Fasting Fed
ApoE/ ApoE/ TIMP3/ p value ApoE/ ApoE/ TIMP3/ p value
PPARa 0.72  0.15 0.36  0.02 0.04 0.46  0.04 0.47  0.06 0.82
PPARb 0.74  0.07 0.74  0.07 0.95 0.45  0.03 0.44  0.03 0.84
PPARg 0.85  0.12 0.79  0.097 0.70 0.26  0.03 0.28  0.04 0.81
FoxO1 1.27  0.38 0.45  0.03 0.0495 1.05  0.12 0.55  0.10 0.03
ERRa 1.92  0.40 1.41  0.22 0.30 0.97  0.12 1.15  0.19 0.44
LXRa 0.96  0.06 0.91  0.08 0.68 0.39  0.02 0.47  0.03 0.03
LXRb 0.79  0.11 0.64  0.11 0.38 0.43  0.06 0.33  0.03 0.28
Ehhadh 0.57  0.15 0.25  0.03 0.08 0.06  0.01 0.09  0.02 0.12
Hadha 1.02  0.11 0.80  0.05 0.09 0.39  0.02 0.45  0.04 0.27
Hadhb 0.68  0.09 0.62  0.09 0.63 0.36  0.02 0.40  0.06 0.54
ACADS 1.29  0.16 1.34  0.19 0.84 0.83  0.14 0.82  0.14 0.98
ACADM 1.29  0.15 0.79  0.13 0.047 0.60  0.05 0.69  0.11 0.43
ACADVL 1.21  0.12 0.90  0.05 0.07 0.60  0.10 0.55  0.06 0.76
ACADL 1.08  0.06 0.97  0.01 0.12 0.57  0.07 0.57  0.07 0.94
CPT1a 1.10  0.11 1.12  0.08 0.89 0.34  0.02 0.50  0.07 0.09
PDK4 1.14  0.08 0.78  0.10 0.03 0.03  0.01 0.07  0.02 0.048
SCD1 0.94  0.04 0.71  0.07 0.02 0.49  0.08 0.52  0.06 0.78
PGC1a 0.57  0.12 0.56  0.08 0.98 0.25  0.02 0.32  0.07 0.29
PGC1b 1.41  0.24 1.44  0.25 0.93 1.01  0.20 1.24  0.14 0.41
GLUT4 1.48  0.24 1.54  0.22 0.85 1.25  0.29 1.17  0.12 0.80
ATG5 0.82  0.08 0.72  0.04 0.30 0.76  0.12 0.73  0.17 0.86
ATG8 1.08  0.36 0.28  0.04 0.04 0.70  0.22 0.23  0.05 0.08
BECN1 0.74  0.08 0.52  0.02 0.03 0.68  0.16 0.55  0.10 0.53
LC3 0.99  0.17 0.52  0.02 0.0498 0.83  0.09 0.74  0.08 0.47
ULK1 0.86  0.12 0.38  0.01 0.02 0.80  0.13 0.40  0.05 0.047
GADD 45 1.49  0.42 2.17  0.35 0.28 0.27  0.08 0.36  0.07 0.45
SESN1 1.12  0.28 1.23  0.12 0.73 0.38  0.12 0.51  0.02 0.36
SESN2 0.88  0.15 0.72  0.02 0.37 0.43  0.09 0.51  0.03 0.42
SOD1 1.10  0.10 1.33  0.03 0.17 0.64  0.06 0.67  0.05 0.71
SOD2 1.07  0.03 1.08  0.12 0.95 0.97  0.15 0.87  0.10 0.62
CAT 0.52  0.16 0.30  0.02 0.22 0.18  0.06 0.13  0.02 0.42
Gene expression by qPCR in the heart of ApoE/Timp3/ and ApoE/mice in the fasting and fed state. Data are mean SEM (Bold indicates p< 0.05 and italics 0.05< p< 0.1,
Student’s t test, n ¼ 4e5 per group).Forkhead box protein O1 (FoxO1), which is involved in energy meta-
bolism, but also in autophagy. Coupled with this, its targets ATG5,
ATG8, BECN1 and LC3 were also downregulated in ApoE/TIMP3/
mice. Decreased autophagy has been related to heart failure and this
reduction might contribute to the reduced heart function we observed
in our model of post-ischemic heart failure [48].
The occurrence of cardiovascular mortality in ApoE/TIMP3/ mice
might reflect a complex interaction between metabolic defects and
tissue remodeling consequent to increased inflammation and tissue
degeneration. Using whole heart mRNA sequencing and subsequent
real-time PCR analysis we revealed apelin as a possible mediator of
the metabolic effects by TIMP3. In ApoE/TIMP3/ mice, we found
apelin to be decreased in the circulation as well as downregulated at
the myocardial level compared to other sites of expression such as the
adipose tissue [49]. Apelin supplementation restored impaired lipid
oxidation in ApoE/TIMP3/ mice. Therefore, our data provide a
molecular clue for the molecular phenotype observed in ApoE/
TIMP3/ mice.
Apelin has recently been shown to rescue defects in insulin resistance
and FAO possibly via regulation of AMPK signaling [27,49]. However,
whether a long-term administration of Apelin is sufficient to prevent
lipid accumulation and which signaling pathways contribute remains to
be investigated.
The effect of TIMP3 on apelin might also explain decreased
heart function in post-ischemic heart failure we observed in the
ApoE/TIMP3/ mice. Patients with left ventricular systolic
dysfunction exhibit decreased myocardial apelin expression in the leftMOLECULAR METABOLISM 4 (2015) 741e752  2015The Authors. Published by Elsevier GmbH. This is an open
www.molecularmetabolism.comventricular wall [50], and experimental in vivo data link apelin to
positive inotropic and regenerative effects in both normal hearts and
post-ischemic heart failure [51e54]. We did not test the effects of
apelin on experimental myocardial infarction. However, it has previ-
ously been shown that in a rat model of post ischemic heart failure,
also using the model of LAD ligation, apelin supplementation was
able to reduce infarction size [55].
ApoE/TIMP3/ mice displayed an impaired oxidative stress
response. Chronic treatment of mice with apelin attenuated pressure-
overload-induced left ventricular hypertrophy, by increasing the
oxidative stress response [56], and decreased ischemia/reperfusion
injury by restoring levels of antioxidant defense [57]. Thus, reduced
apelin levels found in the ApoE/TIMP3/ mice may also be
responsible in part for other metabolomics findings of our study.
Recently, it has been reported that apelin reduces sphingosine kinase 1
activity in cardiac fibroblasts [58] and might therefore increase levels of
sphingosine.
Since reduced apelin levels have also been associated with
arrhythmias [59,60], we hypothesize that reduced apelin may
contribute to the pro-arrythmogenic phenotype that we observed in the
ApoE/TIMP3/ model. However, a positive effect of apelin sup-
plementation on arrhythmias in this model remains to be seen.
We have previously reported that loss of TIMP3 has a role in the
pathogenesis obesity-associated non-alcoholic fatty liver disease
(NAFLD) [8]. We did not measure the lipid content of the liver in this
study, but the fact that the livers of ApoE/TIMP3/ mice reveal
similar defects in the expression of PPARa and FoxO1 targets,accessarticle under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 749
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Figure 7: Loss of TIMP3 leads to disrupted apelin secretion from heart while supplementation can correct some of the metabolic abnormalities in the heart. A) Apelin
expression by qPCR in heart, muscle, adipose tissue and liver reveals a difference between ApoE/TIMP3/ and ApoE/ animals only in the heart (*p < 0.05, one-way ANOVA,
n ¼ 5 per group). B) Circulating apelin levels measured by ELISA were also found to be reduced in the ApoE/TIMP3/ (*p < 0.05, Student’s t test, n ¼ 4 per group). C) Single
dose of intraperitoneally injected apelin restores impaired lipid oxidation of ApoE/TIMP3/ mice during the prolonged fasting state (interval of 8e12 h) measured by indirect
calorimetry. Data are mean  SEM (****p < 0.001, one-way ANOVA, n ¼ 5e6 per group).
Original articleincluding SCD1, suggests that inter-organs crosstalk might be involved
in the phenotype observed. Previous studies have shown that SCD1
deficiency is correlated to diet-induced fatty liver disease. NAFLD has
also been linked to increased cardiovascular risk, myocardial remod-
eling and dysfunction as well as prolongation of QTc interval and thus
increased risk of arrhythmias [61]. However, we did not observe al-
terations in hepatic apelin expression suggesting the involvement of
different pathways. Overall, we cannot exclude that part of the
phenotype is sustained by a liver to heart axis.
Interestingly, metabolomics analysis also revealed an alteration of gut
micro biota-derived (host co-) metabolites such as serotonin, N-ace-
tyltryptophan and 3-indoxyl sulfate in the ApoE/TIMP3/
(Supplementary Table 2). TIMP3 has been shown to regulate
lymphocyte populations [62] as well as to mediate colonic epithelial
barrier disruption through ADAM17 and might, therefore, be involved in
shaping the gut microbiota and regulation of gut microbiota/host in-
teractions, leading to altered immune and metabolic processes.
Backhed and colleagues could show that germ-free mice exhibited
altered gene expression of enzymes involved in fatty acid oxidation
[63]. Therefore, an alteration of the gut microbiota might contribute to
the phenotype observed in the ApoE/TIMP3/ mice.
5. CONCLUSION
TIMP3 maintains cardiac metabolic flexibility in conditions of increased
stress such as myocardial infarction. Deficiency of TIMP3 results in750 MOLECULAR METABOLISM 4 (2015) 741e752  2015 The Authors. Published by Elsevier Gmbperturbations of oxidative stress response, sphingolipid pathway and
lipid metabolism. Reduced levels of apelin found in ApoE/TIMP3/
mice partly explain the defects, and supplementation of apelin rescues
the metabolic phenotype by increasing lipid oxidation.ACKNOWLEDGEMENTS
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